| 标题 |
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Blood 作者:Maël Heiblig; Marcela A. Ferrada; Matthew T. Koster; Thomas Barba; Mathieu Gerfaud-Valentin; et al 出版日期:2022-08-25 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)